Table 2.
Assay results of the 17 NA-resistance samples.
| Sample ID | Gender | Age | NA-resistance | Genotype | G1896A | HBV treatment |
|---|---|---|---|---|---|---|
| P51 | Male | 45 | rtL180M, rtM204I | HBV/C | A | Naïve |
| P103 | Male | 52 | rtL180M, rtM204V | HBV/C | G | LAM + ADV |
| P119 | Male | 48 | rtA181V | HBV/C | G | ADV |
| P160 | Male | 43 | rtN236T | HBV/B | A | Naïve |
| P163 | Male | 48 | rtL180M | HBV/C | A | Naïve |
| P208 | Male | 50 | rtM204I | HBV/C | A | ETV |
| P217 | Female | 57 | rtM204I | HBV/C | A | LdT |
| P227 | Female | 52 | rtM204I | HBV/C | A | ETV |
| P250 | Female | 35 | rtL180M, rtM204I | HBV/C | A | LAM + ADV |
| P279 | Female | 33 | rtA181T | HBV/C | G | LdT + ADV |
| P287 | Female | 32 | rtA181V | HBV/C | A | IFN |
| P304 | Male | 74 | rtL180M | HBV/B | A | ETV |
| P393 | Male | 74 | rtL180M | HBV/B | A | ETV |
| P429 | Female | 53 | rtN236T | HBV/C | G | ETV |
| P487 | Female | 37 | rtA181T | HBV/C | G | ETV |
| P564 | Male | 45 | rtA181T | HBV/C | G | ETV + IFN |
| P600 | Male | 34 | rtN236T | HBV/C | A | Naïve |